Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis

Abstract Background Platelets play an important role in the development of cardiovascular disease (CVD). Mean platelet volume (MPV) is considered as biological marker of platelets activity and function. The aim of the present study was to evaluate MPV values and its possible correlation with arteria...

Full description

Bibliographic Details
Main Authors: Velia Cassano, Giuseppe Armentaro, Domenico Iembo, Sofia Miceli, Teresa V. Fiorentino, Elena Succurro, Maria Perticone, Franco Arturi, Marta L. Hribal, Tiziana Montalcini, Francesco Andreozzi, Giorgio Sesti, Arturo Pujia, Angela Sciacqua
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-024-02177-3
_version_ 1827328733618372608
author Velia Cassano
Giuseppe Armentaro
Domenico Iembo
Sofia Miceli
Teresa V. Fiorentino
Elena Succurro
Maria Perticone
Franco Arturi
Marta L. Hribal
Tiziana Montalcini
Francesco Andreozzi
Giorgio Sesti
Arturo Pujia
Angela Sciacqua
author_facet Velia Cassano
Giuseppe Armentaro
Domenico Iembo
Sofia Miceli
Teresa V. Fiorentino
Elena Succurro
Maria Perticone
Franco Arturi
Marta L. Hribal
Tiziana Montalcini
Francesco Andreozzi
Giorgio Sesti
Arturo Pujia
Angela Sciacqua
author_sort Velia Cassano
collection DOAJ
description Abstract Background Platelets play an important role in the development of cardiovascular disease (CVD). Mean platelet volume (MPV) is considered as biological marker of platelets activity and function. The aim of the present study was to evaluate MPV values and its possible correlation with arterial stiffness and subclinical myocardial damage, in normal glucose tolerance patients (NGT), in newly diagnosed type 2 diabetic (T2DM) patients and in individuals with pre-diabetes. Methods We enrolled 400 newly diagnosed hypertensive patients. All patients underwent an Oral Glucose Tolerance test (OGTT). Arterial stiffness (AS) was evaluated with the measurement of carotid-femoral pulse wave velocity (PWV), augmentation pressure (AP) and augmentation index (AI). Echocardiographic recordings were performed using an E-95 Pro ultrasound system. Results Among groups there was an increase in fasting plasma glucose (FPG) (p < 0.0001), fasting plasma insulin (FPI) (p < 0.0001), high sensitivity c reactive protein (hs-CRP) levels (p < 0.0001) and a decrease in renal function as demonstrated by e-GFR values (p < 0.0001). From the NGT group to the T2DM group there was a rise in MPV value (p < 0.0001). Moreover, in the evaluation of arterial stiffness and subclinical myocardial damage, MPV showed a positive correlation with these parameters. Conclusions In the present study we highlighted that MPV is significantly increased, not only in newly diagnosed T2DM patients, but also in early stage of diabetes, indicating that subjects with pre-diabetes present increased platelets reactivity. Moreover, our results suggest that MPV is associated with increased arterial stiffness and subclinical myocardial damage, indicating MPV as new marker of CV risk.
first_indexed 2024-03-07T15:21:35Z
format Article
id doaj.art-19c4e96807734258a0f95be448884d3f
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-03-07T15:21:35Z
publishDate 2024-03-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-19c4e96807734258a0f95be448884d3f2024-03-05T17:36:47ZengBMCCardiovascular Diabetology1475-28402024-03-0123111010.1186/s12933-024-02177-3Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasisVelia Cassano0Giuseppe Armentaro1Domenico Iembo2Sofia Miceli3Teresa V. Fiorentino4Elena Succurro5Maria Perticone6Franco Arturi7Marta L. Hribal8Tiziana Montalcini9Francesco Andreozzi10Giorgio Sesti11Arturo Pujia12Angela Sciacqua13Department of Medical and Surgical Sciences, University Magna Graecia of CatanzaroDepartment of Medical and Surgical Sciences, University Magna Graecia of CatanzaroDepartment of Medical and Surgical Sciences, University Magna Graecia of CatanzaroDepartment of Medical and Surgical Sciences, University Magna Graecia of CatanzaroDepartment of Medical and Surgical Sciences, University Magna Graecia of CatanzaroDepartment of Medical and Surgical Sciences, University Magna Graecia of CatanzaroDepartment of Medical and Surgical Sciences, University Magna Graecia of CatanzaroDepartment of Medical and Surgical Sciences, University Magna Graecia of CatanzaroDepartment of Medical and Surgical Sciences, University Magna Graecia of CatanzaroResearch Center for the Prevention and Treatment of Metabolic Diseases (CR METDIS), University “Magna Graecia” of CatanzaroDepartment of Medical and Surgical Sciences, University Magna Graecia of CatanzaroDepartment of Clinical and Molecular Medicine, Sapienza University of RomeDepartment of Medical and Surgical Sciences, University Magna Graecia of CatanzaroDepartment of Medical and Surgical Sciences, University Magna Graecia of CatanzaroAbstract Background Platelets play an important role in the development of cardiovascular disease (CVD). Mean platelet volume (MPV) is considered as biological marker of platelets activity and function. The aim of the present study was to evaluate MPV values and its possible correlation with arterial stiffness and subclinical myocardial damage, in normal glucose tolerance patients (NGT), in newly diagnosed type 2 diabetic (T2DM) patients and in individuals with pre-diabetes. Methods We enrolled 400 newly diagnosed hypertensive patients. All patients underwent an Oral Glucose Tolerance test (OGTT). Arterial stiffness (AS) was evaluated with the measurement of carotid-femoral pulse wave velocity (PWV), augmentation pressure (AP) and augmentation index (AI). Echocardiographic recordings were performed using an E-95 Pro ultrasound system. Results Among groups there was an increase in fasting plasma glucose (FPG) (p < 0.0001), fasting plasma insulin (FPI) (p < 0.0001), high sensitivity c reactive protein (hs-CRP) levels (p < 0.0001) and a decrease in renal function as demonstrated by e-GFR values (p < 0.0001). From the NGT group to the T2DM group there was a rise in MPV value (p < 0.0001). Moreover, in the evaluation of arterial stiffness and subclinical myocardial damage, MPV showed a positive correlation with these parameters. Conclusions In the present study we highlighted that MPV is significantly increased, not only in newly diagnosed T2DM patients, but also in early stage of diabetes, indicating that subjects with pre-diabetes present increased platelets reactivity. Moreover, our results suggest that MPV is associated with increased arterial stiffness and subclinical myocardial damage, indicating MPV as new marker of CV risk.https://doi.org/10.1186/s12933-024-02177-3Mean platelets volumeType 2 diabetesPre-diabetesArterial stiffnessGlobal longitudinal strain
spellingShingle Velia Cassano
Giuseppe Armentaro
Domenico Iembo
Sofia Miceli
Teresa V. Fiorentino
Elena Succurro
Maria Perticone
Franco Arturi
Marta L. Hribal
Tiziana Montalcini
Francesco Andreozzi
Giorgio Sesti
Arturo Pujia
Angela Sciacqua
Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
Cardiovascular Diabetology
Mean platelets volume
Type 2 diabetes
Pre-diabetes
Arterial stiffness
Global longitudinal strain
title Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
title_full Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
title_fullStr Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
title_full_unstemmed Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
title_short Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
title_sort mean platelet volume mpv as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
topic Mean platelets volume
Type 2 diabetes
Pre-diabetes
Arterial stiffness
Global longitudinal strain
url https://doi.org/10.1186/s12933-024-02177-3
work_keys_str_mv AT veliacassano meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT giuseppearmentaro meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT domenicoiembo meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT sofiamiceli meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT teresavfiorentino meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT elenasuccurro meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT mariaperticone meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT francoarturi meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT martalhribal meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT tizianamontalcini meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT francescoandreozzi meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT giorgiosesti meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT arturopujia meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis
AT angelasciacqua meanplateletvolumempvasnewmarkerofdiabeticmacrovascularcomplicationsinpatientswithdifferentglucosehomeostasis